Seawolf Therapeutics Debuts With $100 Million Series A
The Series A financing was backed by Versant Ventures, MPM BioImpact, Novartis Venture Fund and Eli Lilly and Company.
The Series A financing was backed by Versant Ventures, MPM BioImpact, Novartis Venture Fund and Eli Lilly and Company.